These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 19538689)

  • 41. GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.
    Chuang DM; Wang Z; Chiu CT
    Front Mol Neurosci; 2011; 4():15. PubMed ID: 21886605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lithium-induced neuroprotective activity in neuronal and microglial cells: A purinergic perspective.
    Gubert C; Andrejew R; Figueiro F; Bergamin L; Kapczinski F; Magalhães PVDS; Battastini AMO
    Psychiatry Res; 2021 Jan; 295():113562. PubMed ID: 33213934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neurobiology of lithium].
    Chazot G; Gogoleva IV; Gromova OA; Ullubiev NM; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():49-55. PubMed ID: 19425290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel mechanism of action for the mood stabilizer lithium.
    Abu-Hijleh FA; Prashar S; Joshi H; Sharma R; Frey BN; Mishra RK
    Bipolar Disord; 2021 Feb; 23(1):76-83. PubMed ID: 33037686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene-expression studies in understanding the mechanism of action of lithium.
    Toker L; Belmaker RH; Agam G
    Expert Rev Neurother; 2012 Jan; 12(1):93-7. PubMed ID: 22243047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium.
    Muzina DJ
    Bipolar Disord; 2009 Jun; 11 Suppl 2():84-91. PubMed ID: 19538688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
    Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
    Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trace lithium and mental health.
    Ishii N; Terao T
    J Neural Transm (Vienna); 2018 Feb; 125(2):223-227. PubMed ID: 29234900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice.
    Coryell W
    Bipolar Disord; 2009 Jun; 11 Suppl 2():77-83. PubMed ID: 19538687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion.
    Zhao WN; Tobe BTD; Udeshi ND; Xuan LL; Pernia CD; Zolg DP; Roberts AJ; Mani D; Blumenthal SR; Kurtser I; Patnaik D; Gaisina I; Bishop J; Sheridan SD; Lalonde J; Carr SA; Snyder EY; Haggarty SJ
    Transl Psychiatry; 2020 Feb; 10(1):76. PubMed ID: 32094324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abelson Helper Integration Site 1 haplotypes and peripheral blood expression associates with lithium response and immunomodulation in bipolar patients.
    Sakrajda K; Bilska K; Czerski PM; Narożna B; Dmitrzak-Węglarz M; Heilmann-Heimbach S; Brockschmidt FF; Herms S; Nöthen MM; Cichon S; Więckowska B; Rybakowski JK; Pawlak J; Szczepankiewicz A
    Psychopharmacology (Berl); 2024 Apr; 241(4):727-738. PubMed ID: 38036661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.
    Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H
    Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment.
    Pisanu C; Congiu D; Manchia M; Caria P; Cocco C; Dettori T; Frau DV; Manca E; Meloni A; Nieddu M; Noli B; Pinna F; Robledo R; Sogos V; Ferri GL; Carpiniello B; Vanni R; Bocchetta A; Severino G; Ardau R; Chillotti C; Zompo MD; Squassina A
    Pharmacogenomics; 2020 Jun; 21(8):533-540. PubMed ID: 32372689
    [No Abstract]   [Full Text] [Related]  

  • 56. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
    Padiath QS; Paranjpe D; Jain S; Sharma VK
    Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.
    McEachin RC; Chen H; Sartor MA; Saccone SF; Keller BJ; Prossin AR; Cavalcoli JD; McInnis MG
    BMC Syst Biol; 2010 Nov; 4():158. PubMed ID: 21092101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.
    Song J; Sjölander A; Joas E; Bergen SE; Runeson B; Larsson H; Landén M; Lichtenstein P
    Am J Psychiatry; 2017 Aug; 174(8):795-802. PubMed ID: 28595491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium: Current Clinical Guidelines for Nurse Practitioners.
    Kverno K
    J Psychosoc Nurs Ment Health Serv; 2022 Jan; 60(1):6-9. PubMed ID: 34978941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage].
    Pronin AV; Gogoleva IV; Torshin IY; Gromovа OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):99-108. PubMed ID: 27166488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.